There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TRACON Pharmaceuticals (TCON – Research Report), Immunocore Holdings (IMCR – Research Report) and Tenaya Therapeutics (TNYA – Research Report) with bullish sentiments.
TRACON Pharmaceuticals (TCON)
H.C. Wainwright analyst Edward White reiterated a Buy rating on TRACON Pharmaceuticals today and set a price target of $12.00. The company’s shares closed last Wednesday at $2.07.
According to TipRanks.com, White has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for TRACON Pharmaceuticals with a $9.00 average price target.
Immunocore Holdings (IMCR)
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Immunocore Holdings today and set a price target of $80.00. The company’s shares closed last Wednesday at $53.95, close to its 52-week high of $56.80.
According to TipRanks.com, Trucchio has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Immunocore Holdings with a $72.50 average price target, implying a 34.3% upside from current levels. In a report issued on August 2, BTIG also initiated coverage with a Buy rating on the stock with a $85.00 price target.
Tenaya Therapeutics (TNYA)
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Tenaya Therapeutics, with a price target of $25.00. The company’s shares closed last Wednesday at $5.49, close to its 52-week low of $4.41.
According to TipRanks.com, Pantginis has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Tenaya Therapeutics is a Strong Buy with an average price target of $26.25.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TCON:
- Analysts Offer Insights on Materials Companies: Franco-Nevada (FNV) and Yield10 Bioscience (YTEN)
- Primo Water Corporation Announces Strong Second Quarter 2022 Results and Raises Full Year Guidance
- Magic Software Reports Second Quarter 2022 Financial Results with Record Second Quarter Revenues of $137 Million, Reflecting a 15% Year Over Year Growth
- These Stocks Are the Biggest Pre-Market Movers on Thursday
- H.C. Wainwright Sticks to Its Buy Rating for Vir Biotechnology (VIR)